封面
市场调查报告书
商品编码
1708472

全球葡萄糖生物感测器市场(按技术、应用、最终用途和地区)

Global Glucose Biosensor Market, By Technology, By Application, By End Use, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计 2025 年全球葡萄糖生物感测器市场规模为 117.9 亿美元,到 2032 年将达到 200.7 亿美元,2025 年至 2032 年的复合年增长率为 7.9%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 117.9亿美元
效能数据 2020-2024 预测期 2025-2032
预测期:2025-2032年复合年增长率: 7.90% 2032年价值预测 207亿美元
数字。 2025年全球市场占有率(%)
全球葡萄糖生物感测器市场-IMG1

预计全球葡萄糖生物感测器市场在预测期内将显着增长。葡萄糖生物感测器是一种用于检测生物样本中葡萄糖浓度的分析装置。它们包含葡萄糖氧化酵素酶和葡萄糖结合蛋白质等生物辨识元素。生物辨识元件固定在物理化学换能器上,将生物事件转换为可量化的分析讯号。糖尿病盛行率的不断上升以及自我监测和居家照护的严格监管通讯协定是推动该市场成长的主要因素。微创、低成本、高精度和用户友好的生物感测器的技术进步正在加速其在照护现场和家庭应用中的普及。

市场动态:

全球葡萄糖生物感测器市场的成长受到全球老年人口不断增加和糖尿病盛行率上升的推动。根据国际糖尿病联盟的数据显示,2020年全球约有4.63亿成年人(20-79岁)患有糖尿病,预计到2045年这一数字将上升至7亿,导致自我监测血糖的需求大幅增加。此外,优惠的报销政策和政府推动自我血糖监测的倡议也推动了市场的成长。然而,预计在预测期内,严格的监管核准和与生物感测器相关的高成本将在一定程度上阻碍市场扩张。从积极的一面来看,正在进行的可穿戴、非侵入性、智慧型手机整合生物感测器的研究和开发工作正在开闢新的途径。

本研究的主要特点

  • 本研究报告对全球葡萄糖生物感测器市场进行了详细分析,并给出了预测期(2025-2032)的市场规模和年复合成长率(CAGR),假设 2024 年为基准年。
  • 它还强调了各个领域的潜在收益成长机会,并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 它根据公司亮点、产品系列、关键亮点、性能和策略等参数介绍了全球葡萄糖生物感测器市场的主要企业概况。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球葡萄糖生物感测器市场报告针对该行业的各个相关人员,例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 相关人员可以透过用于分析全球葡萄糖生物感测器市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 糖尿病盛行率不断上升
    • 人口老化加剧
    • 严格的监理政策
  • 主要亮点
  • 监管情景
  • 近期动态
  • PEST分析
  • 波特分析
  • 产品发布
  • 合併、收购和合作

4. 全球葡萄糖生物感测器市场-冠状病毒(COVID-19)大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 全球葡萄糖生物感测器市场(依技术划分),2020 年至 2032 年

  • 酵素生物感测器
  • 非酵素生物感测器

6. 全球葡萄糖生物感测器市场(按应用划分),2020 年至 2032 年

  • 家庭诊断
  • 医院和诊所
  • 研究与开发

7. 2020 年至 2032 年全球葡萄糖生物感测器市场(按最终用户划分)

  • 医院
  • 居家护理
  • 诊断中心

8. 全球葡萄糖生物感测器市场(按地区),2020-2032

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东
  • 非洲

第九章 竞争态势

  • 公司简介
    • Abbott Laboratories
    • Dexcom
    • Ascenia Diabetes Car Company Highlights
    • Nova Diabetes Care
    • F.Hoffmann-La Roche Ltd.
    • Sanofi
    • GlySens Incorporated
    • Trividia Health
    • Bayer
    • Lifescan

第 10 章 章节

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6631

Global Glucose Biosensor Market is estimated to be valued at USD 11.79 Bn in 2025 and is expected to reach USD 20.07 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 11.79 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.90% 2032 Value Projection: USD 20.07 Bn
Figure. Global Glucose Biosensor Market Share (%), By Region 2025
Global Glucose Biosensor Market - IMG1

The global glucose biosensor market is poised to grow at a significant rate over the forecast period. A glucose biosensor is an analytical device used for the detection of glucose concentration in biological samples. It incorporates a bio-recognition element like glucose oxidase enzyme or glucose-binding protein. The bio-recognition element is immobilized on a physicochemical transducer that transforms the biological event into a quantifiable analytical signal. Increased prevalence of diabetes and stringent regulatory protocols related to self-monitoring and homecare are the key factors driving the growth of this market. Technological advancements in developing minimally invasive, low-cost, accurate, and user-friendly biosensor have accelerated their adoption in point-of-care and home-use applications.

Market Dynamics:

The growth of the global glucose biosensor market is driven by rising geriatric population and increasing incidence of diabetes across the world. As per the International Diabetes Federation, around 463 million adults (20-79 years) were living with diabetes in 2020 and the number is projected to increase to 700 million by 2045. This has significantly increased the demand for self-monitoring of blood glucose. Moreover, favorable reimbursement policies and government initiatives to promote self-monitoring are providing impetus to the market growth. However, stringent regulatory approvals and high costs associated with biosensor are expected to hinder the market expansion to some extent during the forecast period. On the positive side, ongoing R&D to develop wearable, non-invasive, and smartphone integrated biosensor opens new avenues.

Key Features of the Study:

  • This report provides an in-depth analysis of the global glucose biosensor market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global glucose biosensor market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Abbott Laboratories, Dexcom, Ascenia Diabetes Care, Nova Diabetes Care, F. Hoffmann-La Roche Ltd., Sanofi, GlySens Incorporated, Trividia Health, Bayer, and Lifescan.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global glucose biosensor market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global glucose biosensor market.

Detailed Segmentation:

  • Global Glucose Biosensor Market, By Technology
    • Enzymatic Biosensor
    • Non-Enzymatic Biosensor
  • Global Glucose Biosensor Market, By Application
    • Home Diagnostics
    • Hospitals and Clinics
    • Research and Development
  • Global Glucose Biosensor Market, By End Use
    • Hospitals
    • Homecare
    • Diagnostic centers
  • Global Glucose Biosensor Market, By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Abbott Laboratories
    • Dexcom
    • Ascenia Diabetes Care
    • Nova Diabetes Care
    • Hoffmann-La Roche Ltd.
    • Sanofi
    • GlySens Incorporated
    • Trividia Health
    • Bayer
    • Lifescan

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Technology
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rising prevalence of diabetes
    • Growing geriatric population
    • Stringent regulatory policies
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • PEST Analysis
  • PORTER's Analysis
  • Product Launches
  • Mergers, Acquisitions, and Collaborations

4. Global Glucose Biosensor Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Glucose Biosensor Market, By Technology, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Enzymatic Biosensors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Non-Enzymatic Biosensors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Glucose Biosensor Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Home Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Research and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Glucose Biosensor Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Homecare
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Diagnostic centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Glucose Biosensor Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profile
    • Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Dexcom
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Ascenia Diabetes Car Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Nova Diabetes Care
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • F.Hoffmann-La Roche Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • GlySens Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Trividia Health
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Bayer
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Lifescan
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us